Myelodysplastic syndrome patient-derived xenografts: from no options to many
Haematologica
.
2020 Apr;105(4):864-869.
doi: 10.3324/haematol.2019.233320.
Epub 2020 Mar 19.
Authors
Christophe Côme
1
2
3
,
Alexander Balhuizen
1
2
3
,
Dominique Bonnet
4
,
Bo T Porse
5
2
3
Affiliations
1
The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark.
2
Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.
3
Danish Stem Cell Center (DanStem), Faculty of Health Sciences, University of Copenhagen, Denmark.
4
Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, UK.
5
The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark bo.porse@finsenlab.dk.
PMID:
32193253
PMCID:
PMC7109759
DOI:
10.3324/haematol.2019.233320
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Animals
Disease Models, Animal
Heterografts
Humans
Myelodysplastic Syndromes* / genetics
Grants and funding
WT_/Wellcome Trust/United Kingdom
FC001045/CRUK_/Cancer Research UK/United Kingdom
FC001045/WT_/Wellcome Trust/United Kingdom
FC001045/MRC_/Medical Research Council/United Kingdom